These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25188235)

  • 21. β-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain.
    Huang L; Deng M; He Y; Lu S; Ma R; Fang Y
    Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):634-43. PubMed ID: 26991136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal norepinephrine efflux in l-DOPA-induced dyskinesia.
    Ostock CY; Bhide N; Goldenberg AA; George JA; Bishop C
    Neurochem Int; 2018 Mar; 114():85-98. PubMed ID: 29371053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The roles of striatal serotonin and L -amino-acid decarboxylase on L-DOPA-induced Dyskinesia in a Hemiparkinsonian rat model.
    Gil S; Park C; Lee J; Koh H
    Cell Mol Neurobiol; 2010 Aug; 30(6):817-25. PubMed ID: 20232137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
    Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
    Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
    Brannan T; Bhardwaj A; Martinez-Tica J; Weinberger J; Yahr M
    J Neural Transm Park Dis Dement Sect; 1990; 2(1):15-22. PubMed ID: 2113388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
    King JM; Muthian G; Mackey V; Smith M; Charlton C
    Life Sci; 2011 Oct; 89(17-18):638-43. PubMed ID: 21871902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease.
    Kamińska K; Lenda T; Konieczny J; Wardas J; Lorenc-Koci E
    Neurochem Int; 2018 Dec; 121():125-139. PubMed ID: 30290201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry.
    De Deurwaerdère P; Di Giovanni G; Millan MJ
    Prog Neurobiol; 2017 Apr; 151():57-100. PubMed ID: 27389773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
    Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA
    J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity.
    Miyazaki I; Asanuma M; Kikkawa Y; Takeshima M; Murakami S; Miyoshi K; Sogawa N; Kita T
    Glia; 2011 Mar; 59(3):435-51. PubMed ID: 21264950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of L-DOPA transport in cultured rat and mouse astrocytes.
    Tsai MJ; Lee EH
    J Neurosci Res; 1996 Feb; 43(4):490-5. PubMed ID: 8699535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norepinephrine transporter inhibition with desipramine exacerbates L-DOPA-induced dyskinesia: role for synaptic dopamine regulation in denervated nigrostriatal terminals.
    Chotibut T; Fields V; Salvatore MF
    Mol Pharmacol; 2014 Dec; 86(6):675-85. PubMed ID: 25208966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter.
    Arai A; Tomiyama M; Kannari K; Kimura T; Suzuki C; Watanabe M; Kawarabayashi T; Shen H; Shoji M
    Synapse; 2008 Aug; 62(8):632-5. PubMed ID: 18509855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.
    Nowak P; Bortel A; Dabrowska J; Biedka I; Slomian G; Roczniak W; Kostrzewa RM; Brus R
    Neurotox Res; 2008; 13(3-4):231-40. PubMed ID: 18522902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease.
    Eskow Jaunarajs KL; George JA; Bishop C
    Neuroscience; 2012 Aug; 218():243-56. PubMed ID: 22659568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.
    Carta M; Lindgren HS; Lundblad M; Stancampiano R; Fadda F; Cenci MA
    J Neurochem; 2006 Mar; 96(6):1718-27. PubMed ID: 16539687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
    St-Hilaire M; Landry E; Lévesque D; Rouillard C
    Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.